|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Platelet thromboxane(11-dehydro-Thromboxane B_2) and aspirin response in patients with diabetes and coronary artery disease显示文摘Aspirin(ASA) irreversibly inhibits platelet cyclooxygenase-1(COX-1) leading to decreased thromboxane-mediated platelet activation. The effect of ASA ingestion on thromboxane generation was evaluated in patients with diabetes(DM) and cardiovascular disease. Thromboxane inhibition was assessed by measuring the urinary excretion of 11-dehydro-thromboxane B2(11dhTxB2), a stable metabolite of thromboxane A2. The mean baseline urinary 11dhTxB2 of DM was 69.6% higher than healthy controls(P = 0.024): female subjects(DM and controls) had 50.9% higher baseline 11dhTxB2 than males(P = 0.0004), while age or disease duration had no influence. Daily ASA ingestion inhibited urinary 11dhTxB2 in both DM(71.7%) and controls(75.1%, P < 0.0001). Using a pre-established cut-off of 1500 pg/mg of urinary 11dhTxB2, there were twice as many ASA poor responders(ASA 'resistant') in DM than in controls(14.8% and 8.4%, respectively). The rate of ASA poor responders in two populations of acute coronary syndrome(ACS) patients was 28.6 and 28.7%, in spite of a significant(81.6%) inhibition of urinary 11dhTxB2(P < 0.0001). Both baseline 11dhTxB2 levels and rate of poor ASA responders were significantly higher in DM and ACS compared to controls. Underlying systemic oxidative inflammation may maintain platelet function in atherosclerotic cardiovascular disease irrespective of COX-1 pathway inhibition and/or increase systemic generation of thromboxane from non-platelet sources. | Luis R Lopez Kirk E Guyer Ignacio Garcia De La Torre Kelly R Pitts Eiji Matsuura Paul RJ Ames | 2014 | World Journal of Diabetes2014，5，2： | 13 |
| 2 | Role of CARD15,DLG5 and OCTN genes polymorphisms in children with inflammatory bowel diseases显示文摘AIM: To investigate the contribution of variants of CARD15, OCTN1/2 and DLG5 genes in disease predispo- sition and phenotypes in a large Italian cohort of pediatric patients with inflammatory bowel diseases (IBD). METHODS: Two hundred patients with Crohn’s disease (CD), 186 ulcerative colitis (UC) patients, 434 par- ents (217 trios), and 347 healthy controls (HC) were studied. Polymorphisms of the three major variants of CARD15, 1672C/T and -207G/C SNPs for OCTN genes, IGR2096a_1 and IGR2198a_1 SNPs for the IBD5 locus, and 113G/A variant of the DLG5 gene were evaluated. Potential correlations with clinical sub-phenotypes were investigated. RESULTS: Polymorphisms of CARD15 were significantly associated with CD, and at least one variant was found in 38% of patients (15% in HC, OR = 2.7, P < 0.001). Homozygosis for both OCTN1/2 variants was more com- mon in CD patients (1672TT 24%, -207CC 29%) than in HC (16% and 21%, respectively; P = 0.03), with an in- creased frequency of the TC haplotype (44.8% vs 38.3% in HC, P = 0.04). No association with the DLG5 variant was found. CD carriers of OCTN1/2 and DLG5 variants more frequently had penetrating disease (P = 0.04 and P = 0.01), while carriers of CARD15 more frequently had ileal localization (P = 0.03). No gene-gene interaction was found. In UC patients, the TC haplotype was morefrequent (45.4%, P = 0.03), but no genotype/phenotype correlation was observed. CONCLUSION: Polymorphisms of CARD15 and OCTN genes, but not DLG5 are associated with pediatric on- set of CD. Polymorphisms of CARD15, OCTN, and DLG5 genes exert a weak influence on CD phenotype. | S Cucchiara A Latiano O Palmieri AM Staiano R D'Incà G Guariso G Vieni V Rutigliano O Borrelli MR Valvano V Annese | 2007 | World Journal of Gastroenterology2007，13，8： | 9 |
| 3 | Advantages of using the CRISPR/Cas9 system of genome editing to investigate male reproductive mechanisms using mouse models显示文摘基因混乱技术长为男繁殖生物学的学习是有益的。因为包含的时间和费用,除了在专家实验室,然而,这种技术不是一个可行方法。基因混乱的 CRISPR/Cas9 系统的来临迎来了基因调查的一个新时代。现在,在很小的时间并且以很小的成本产生破坏基因的老鼠模型是可能的。这篇热点文章讨论这种技术的应用程序在一些能被用来揭示男繁殖机制的必要、非本质的基因部件的这个系统的未来使用学习男富饶和外表的遗传。 | Samantha AM Young R John Aitken Masahito Ikawa | 2015 | Asian Journal of Andrology2015，17，4： | 4 |
| 4 | Current status of clinical islet transplantation显示文摘Islet transplantation(IT) is today a well-established treatment modality for selected patients with type 1 diabetes mellitus(T1DM). After the success of the University of Alberta group with a modified approach to the immune protection of islets, the international experience grew along with the numbers of transplants in highly specialized centers. Yet, long-term analysis of those initial results from the Edmonton group indicated that insulin-independence was not durable and most patients return to modest amounts of insulin around the fifth year, without recurrent hypoglycemia events. Many phenomena have been identified as limiting factor for the islet engraftment and survival, and today all efforts are aimed to improve the quality of islets and their engrafting process, as well as more optimized immunosuppression to facilitate tolerance and ultimately, better long term survival. This brief overview presents recent progress in IT. A concise historical perspective is provided, along with the latest efforts to improve islet engraftment, immune protection and ultimately, prolonged graft survival. It is apparent that as the community continues to work together further optimizing IT, it is hopeful a cure for T1 DM will soon be achievable. | Andrew R Pepper Boris Gala-Lopez Oliver Ziff AM James Shapiro | 2013 | World Journal of Transplantation2013，3，4： | 3 |
| 5 | Treatment of hepatitis C virus genotype 4 with peginterferon alfa-2a: Impact of bilharziasis and fibrosis stage显示文摘AIM: To evaluate pegylated interferon alpha2a (PegIFN- α2a) in Egyptian patients with HCV genotype 4, and the impact of pretreatment viral load, co-existent bilharziasis and histological liver changes on response rate. METHODS: A total of 73 na?ve patients (61 with history of bilharziasis) with compensated chronic HCV genotype 4 were enrolled into: group A (38 patients) who received 180 mg PegIFN-alpha2a subcutaneously once weekly for a year and group B (35 patients) received IFN alpha-2a 3 MU 3 times weekly. Ribavirin was added to each regimen at a dose of 1200 mg. Patients were followed for 72 wk and sustained response was assessed. RESULTS: Significant improvement in both end of treatment response (ETR) (P < 0.002) and sustained response (SR) (P < 0.05) was noted with pegylated interferon, where ETR was achieved in 29 (76.3%) and 14 patients (40%) in both groups respectively, and 25 patients in group A (65.8%) and 9 (25.7%) in group B could retain negative viraemia by the end of follow up period. Sustained virological response (SVR) showed a significant negative correlation with age and positive correlation with pretreatment inflammation in patients receiving PegIFN. Viral clearance after 3 mo of therapy was associated with high incidence of ETR and SR (P < 0.001), but without significant difference between both forms of interferon. Significant improvement in response was achieved in patients with high grade fibrosis (grade 3 and 4) with PegIFN-α2a, where SR was seen in 5 out of 13 patients in group A, but none in group B. There was no significant difference in response betweenbilharzial and non-bilharzial patients in both groups. In terms of safety and tolerability, neutropenia was the predominant side effect; both drugs were comparable. CONCLUSION: PegIFN-α2a combined with ribavirin results in improvement in sustained response in HCV genotype 4, irrespective of history of bilharzial infestation. | MF Derbala SR Al Kaabi NZ El Dweik F Pasic MT Butt R Yakoob A Al-Marri AM Amer N Morad A Bener | 2006 | World Journal of Gastroenterology2006，12，35： | 3 |
| 6 | Human urotensinⅡis a potent vasoconstrictory and agonist for the orphan receptor GPR14 显示文摘 | Ames R S Sarau H M Chambers J K | 1999 | Nature1999，401，6750： | 3 |
| 7 | Effect of an aldose reductase inhibitor on type Ⅳ collagen production by human endothelial cells cultured in high glucose显示文摘 | Bakillah A Grigorova Borsos AM Guillot R | 1996 | Diabetologia1996，39，： | 2 |
| 8 | Ceramometal crowns and bridges: A focus on failures 显示文摘 | Bell AM Kuazeja R Gamberg MG | 1985 | Dent Clin North Am1985，29，： | 2 |
| 9 | 在确诊并已接受治疗的原发性高血压患者中,炎症、内皮功能障碍和交感神经激活与血压之间的关系显示文摘研究结果表明,炎症、内皮功能紊乱、交感神经系统慢性激活在高血压发病机制中起重要作用。目前临床上关于血压与炎症、内皮功能紊乱以及交感神经系统激活之间的关系还不明确。该研究评估在确诊并已接受治疗的原发性高血压患者中,炎症[高敏C反应蛋白(high-sensitivity C-reactive protein,hsCRP)]、内皮细胞功能紊乱(内皮素1)和交感神经慢性激活(血浆肾上腺素和去甲肾上腺素)的生物标记物水平是否与血压的测量值相关。研究者同时试图应用血压和上述标记物之间的关系诊断顽固性高血压,并探讨降压药物对上述生物标记物的影响。 | Tycinska AM Mroczko B Musial WJ Sawicki R Kaminski K Borowska H Sobkowicz B Szmitkowski M. 叶鹏 | 2011 | 中华高血压杂志2011，19，11： | 2 |
| 10 | Molecular microbial ecology of lignocellulose mobilisation as a carbon source in mine drainage wastewater treatment显示文摘 | Clarke AM Kirby R Rose PD | 2007 | 中国生物学文摘2007，21，6： | 2 |
| 11 | Virus - induced gene silencing in plants 显示文摘 | Lu R Martin - Hemandez AM Peart JR | 2003 | Methods2003，30，： | 1 |
| 12 | Roles of TGF-beta in hepatic fibrosis 显示文摘 | Gressner AM Weiskirchen R Breitkopf K | 2002 | Front Biosci2002，7，： | 1 |
| 13 | Peroxynitfite activates glucose uptake in 3T3-L1 adipocytes through a P13-K-dependent mechanism显示文摘 | Guzman-Grenfell AM Garcia-Macedo R Gonzalez-Martinez MT et al | 2005 | Front Biosci2005，10，1： | 1 |
| 14 | Non-invasive quantification of liver perfusion with dynamic computed tomography and a dual-input one compartment model显示文摘 | Van Beers BE Smith AM | 2000 | Clin Sci2000，99，6： | 1 |
| 15 | Antioxidatant activity of albumin-bound bilirubin显示文摘 | Glazer AN Ames BN | 1987 | Proc Natl Acad Sci USA1987，84，： | 1 |
| 16 | Temporal dynamics of CD69 expression only mphoid cells显示文摘 | Koh M Dermott AM | 1997 | lmmuno Methods1997，209，： | 1 |
| 17 | Donor comm itmen and patient needs显示文摘 | Bakken R Van-Walreaven AM Egeland T | 2004 | Bone Marrow Transplant2004，33，2： | 1 |
| 18 | The anti inflammatory effect of sepsis is mediated by up-regulation of peroxisome proliferator activated receptor-gamma显示文摘 | Siddiqui AM Cui X Wu R | 2006 | Crit Care Med2006，34，： | 1 |
| 19 | A severe case of insomnia in the form of paradoxical insomnia显示文摘 | Lapinlampi AM Mkel R | 2008 | Gen Hosp Psychiatry2008，30，5： | 1 |
| 20 | Oestrogen and the colon: potential mechanisms for cancer prevention显示文摘 | Kennelly R Kavanagh DO ttogan AM | 2008 | Lancet Oncol2008，9，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员